tirzepatide dry eyes and Macular Degeneration: Current Evidence and Monitoring Weight-Loss Drug Linked to Lower

doi: 10.1016/J.NEUROPHARM.2023.109716

Evidence While clinical data strongly demonstrate weight loss and metabolic benefits with GLP-1s, current trials are evaluating their potential in inflammatory adipose diseases such as lipedema

No, weight loss injections should not be used during pregnancy due to insufficient human safety data and potential risks to foetal development

Mientras persista el problema de suministro, y ante la posibilidad de no poder iniciar/continuar el tratamiento por ausencia del medicamento en el mercado, se recomienda sustituir el tratamiento por alguno de los medicamentos disponibles del mismo grupo teraputico: Byetta (exenatida